SYNAPTICS Inc — Director's Dealing 2020

Aug 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2020-08-10

Reporting Person: NOLAN KERMIT (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-10	Common Stock	M	408	$62.105	Acquired	51401	Direct
2020-08-10	Common Stock	M	408	$76.81	Acquired	51809	Direct
2020-08-10	Common Stock	M	1050	$73.31	Acquired	52859	Direct
2020-08-10	Common Stock	M	1049	$71.55	Acquired	53908	Direct
2020-08-10	Common Stock	M	1050	$51.95	Acquired	54958	Direct
2020-08-10	Common Stock	S	8058	$85.3999	Disposed	46900	Direct
2020-08-10	Common Stock	S	2369	$86.2078	Disposed	44531	Direct
2020-08-10	Common Stock	S	1149	$87.789	Disposed	43382	Direct
2020-08-10	Common Stock	S	377	$88.9295	Disposed	43005	Direct
2020-08-10	Common Stock	S	12	$89.6398	Disposed	42993	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-10	Employee Stock Option (Right to Buy)	$62.105	M	408	Disposed	2021-10-24	Common Stock (408)	Direct
2020-08-10	Employee Stock Option (Right to Buy)	$76.81	M	408	Disposed	2022-01-30	Common Stock (408)	Direct
2020-08-10	Employee Stock Option (Right to Buy)	$73.31	M	1050	Disposed	2023-01-29	Common Stock (1050)	Direct
2020-08-10	Employee Stock Option (Right to Buy)	$71.55	M	1049	Disposed	2023-04-29	Common Stock (1049)	Direct
2020-08-10	Employee Stock Option (Right to Buy)	$51.95	M	1050	Disposed	2023-07-29	Common Stock (1050)	Direct

Footnotes

F1: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 18, 2020.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.81 to $85.78, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.83 to $86.82, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.35 to $87.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.42 to $88.99, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.50 to $89.6525, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 24, 2014 date of grant, until fully vested on October 24, 2017.

F8: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 30, 2015 date of grant, until fully vested on January 30, 2018.

F9: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 29, 2016 date of grant, until fully vested on January 29, 2019.

F10: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 29, 2016 date of grant, until fully vested on April 29, 2019.

F11: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 29, 2016 date of grant, until fully vested on July 29, 2019.